Cargando…

Prevalence and Characteristics of Polyneuropathy in Atypical Parkinsonian Syndromes: An Explorative Study

(1) Background: Peripheral nerve involvement is increasingly recognized in Parkinson’s disease (PD). Although non-motor symptoms and postural instability are early features of atypical parkinsonian syndromes (APS), peripheral neuropathies in APS have not been addressed in detail thus far. Therefore,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rohmann, Rachel, Kühn, Eva, Scherbaum, Raphael, Hilker, Lovis, Kools, Saskia, Scholz, Leonard, Müller, Katharina, Huckemann, Sophie, Schneider-Gold, Christiane, Gold, Ralf, Pitarokoili, Kalliopi, Tönges, Lars, Kwon, Eun Hae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301815/ https://www.ncbi.nlm.nih.gov/pubmed/34209067 http://dx.doi.org/10.3390/brainsci11070879

Ejemplares similares

Vagal cross-sectional area correlates with parasympathetic dysfunction in Parkinson's disease
por: Huckemann, Sophie, et al.
Publicado: (2023)

Correlates of polyneuropathy in Parkinson’s disease
por: Kühn, Eva, et al.
Publicado: (2020)

Data-driven subtyping of Parkinson’s disease: comparison of current methodologies and application to the Bochum PNS cohort
por: Chen, Qiang, et al.
Publicado: (2023)

Comprehensive approaches for diagnosis, monitoring and treatment of chronic inflammatory demyelinating polyneuropathy
por: Fisse, Anna Lena, et al.
Publicado: (2020)

Nerve Ultrasound Distinguishes Non-Inflammatory Axonal Polyneuropathy From Inflammatory Polyneuropathy With Secondary Axonal Damage
por: Brünger, Jil, et al.
Publicado: (2022)

High-resolution nerve ultrasound and magnetic resonance neurography as complementary neuroimaging tools for chronic inflammatory demyelinating polyneuropathy
por: Pitarokoili, Kalliopi, et al.
Publicado: (2018)

Nerve Echogenicity in Polyneuropathies of Various Etiologies—Results of a Retrospective Semi-Automatic Analysis of High-Resolution Ultrasound Images
por: Erdmann, Anke, et al.
Publicado: (2022)

Hospital Admissions for Neurodegenerative Diseases during the First Wave of the COVID-19 Pandemic: A Nationwide Cross-Sectional Study from Germany
por: Scherbaum, Raphael, et al.
Publicado: (2021)

Clinical Profiles and Mortality of COVID‐19 Inpatients with Parkinson's Disease in Germany
por: Scherbaum, Raphael, et al.
Publicado: (2021)

Parkinson’s Disease Multimodal Complex Treatment (PD-MCT): Analysis of Therapeutic Effects and Predictors for Improvement
por: Hartelt, Elke, et al.
Publicado: (2020)

Analysis of nationwide multimodal complex treatment and drug pump therapy in Parkinson's disease in times of COVID-19 pandemic in Germany
por: Richter, Daniel, et al.
Publicado: (2021)

COVID-19 outcomes in hospitalized Parkinson’s disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany
por: Scherbaum, Raphael, et al.
Publicado: (2022)

Corneal inflammatory cell infiltration predicts disease activity in chronic inflammatory demyelinating polyneuropathy
por: Motte, Jeremias, et al.
Publicado: (2021)

Parkinson’s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study
por: Scherbaum, Raphael, et al.
Publicado: (2022)

Evaluation of the EFNS/PNS diagnostic criteria in a cohort of CIDP patients
por: Athanasopoulos, Diamantis, et al.
Publicado: (2021)

Dimethyl Fumarate Ameliorates Lewis Rat Experimental Autoimmune Neuritis and Mediates Axonal Protection
por: Pitarokoili, Kalliopi, et al.
Publicado: (2015)

Lentiform Nucleus Hyperechogenicity in Parkinsonian Syndromes: A Systematic Review and Meta-Analysis with Consideration of Molecular Pathology
por: Richter, Daniel, et al.
Publicado: (2019)

New Approaches to Critical Illness Polyneuromyopathy: High-Resolution Neuromuscular Ultrasound Characteristics and Cytokine Profiling
por: Fisse, Anna Lena, et al.
Publicado: (2020)

Antibody-based immunotherapies for Parkinsonian syndromes
por: Tönges, Lars, et al.
Publicado: (2019)

Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection
por: Ambrosius, Björn, et al.
Publicado: (2017)

Significance of clinical symptoms and red flags in early differential diagnosis of Parkinson’s disease and atypical Parkinsonian syndromes
por: Schröter, Nils, et al.
Publicado: (2023)

Epidemiology of atypical parkinsonian syndromes
por: Lo, Raymond Y.
Publicado: (2021)

Treatment of an acute motor and sensory axonal neuropathy with propionate in a 33-year-old male
por: Yoon, Min-Suk, et al.
Publicado: (2018)

Neuropsychiatric disturbances in atypical parkinsonian disorders
por: Belvisi, Daniele, et al.
Publicado: (2018)

Treatment response to cyclophosphamide, rituximab, and bortezomib in chronic immune-mediated sensorimotor neuropathies: a retrospective cohort study
por: Motte, Jeremias, et al.
Publicado: (2021)

Fracture Risk Assessment in Atypical Parkinsonian Syndromes
por: Kobylecki, Christopher, et al.
Publicado: (2021)

Capsaicin-enriched diet ameliorates autoimmune neuritis in rats
por: Motte, Jeremias, et al.
Publicado: (2018)

Hereditary defect of cobalamin metabolism with adolescence onset resembling multiple sclerosis: 41-year follow up in two cases
por: Motte, Jeremias, et al.
Publicado: (2019)

Update on CSF Biomarkers in Parkinson’s Disease
por: Kwon, Eun Hae, et al.
Publicado: (2022)

Dynamics of Parkinson’s Disease Multimodal Complex Treatment in Germany from 2010–2016: Patient Characteristics, Access to Treatment, and Formation of Regional Centers
por: Richter, Daniel, et al.
Publicado: (2019)

Dose-dependent immunomodulatory effects of bortezomib in experimental autoimmune neuritis
por: Klimas, Rafael, et al.
Publicado: (2021)

Biosignatures for Parkinson’s Disease and Atypical Parkinsonian Disorders Patients
por: Potashkin, Judith A., et al.
Publicado: (2012)

Differentiating atypical parkinsonian syndromes—a way forward?
por: Pfeiffer, Ronald F
Publicado: (2015)

Sensor‐based gait analysis in atypical parkinsonian disorders
por: Raccagni, Cecilia, et al.
Publicado: (2018)

Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes
por: Saeed, Usman, et al.
Publicado: (2020)

Therapeutic Application of rTMS in Atypical Parkinsonian Disorders
por: Petsani, Chrysi, et al.
Publicado: (2021)

Induction of Regulatory Properties in the Intestinal Immune System by Dimethyl Fumarate in Lewis Rat Experimental Autoimmune Neuritis
por: Pitarokoili, Kalliopi, et al.
Publicado: (2019)

Intrathecal triamcinolone acetonide exerts anti-inflammatory effects on Lewis rat experimental autoimmune neuritis and direct anti-oxidative effects on Schwann cells
por: Pitarokoili, Kalliopi, et al.
Publicado: (2019)

Neurological update: non-motor symptoms in atypical parkinsonian syndromes
por: Ananthavarathan, Piriyankan, et al.
Publicado: (2023)

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience
por: Schneider-Gold, Christiane, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h1grnh3cm4cqpbsad2ut9kidsk